This study compared canagliflozin (Invokana) to teneligliptin (Teneria) for patients with type 2 diabetes (T2D). It found that canagliflozin led to greater improvement in body weight and metabolic outcomes in these patients.

This review examined whether patient education can prevent foot ulcers in diabetics.

This review examined the factors which make a behavioral program for type 2 diabetes management effective. The authors concluded that patients who have poorly controlled diabetes are likely to gain the greatest benefit.

This study examined whether meal sequence affects blood glucose levels in individuals with type 2 diabetes. The authors concluded that meal sequence affects blood glucose levels after a meal and nutritional therapy may be important in managing type 2 diabetes.

This study examined whether there is a link between type 2 diabetes (T2D) and osteoarthritis. They found that patients with T2D were more likely to develop osteoarthritis. 

This study examined whether high blood glucose levels can alter the function of arteries. The authors concluded that type 2 diabetes patients, particularly those with decreased kidney function, have higher arterial stiffness after experiencing high blood glucose levels.

The authors evaluated the risk of autoimmune disease development in patients starting a dipeptidyl peptidase inhibitor for type 2 diabetes.

This study investigated whether weight loss surgery improved remission rates and reduced related complications in obese type 2 diabetes patients. 

The authors aimed to assess patient-reported outcomes associated with initiating insulin glargine among insulin-naïve patients with type 2 diabetes mellitus.